Literature DB >> 10583508

Cloning and characterization of two neural-salient serine/arginine-rich (NSSR) proteins involved in the regulation of alternative splicing in neurones.

M Komatsu1, E Kominami, K Arahata, T Tsukahara.   

Abstract

BACKGROUND: In neurones, alternative splicing regulates the functions of many gene products. However, the molecular basis of neural-specific splicing, and how splicing regulation is modulated in different neurones remains to be determined.
RESULTS: We cloned two new SR proteins, Neural-salient SR proteins (NSSR) 1 and 2, which are present at higher levels in brain and testis. During the differentiation, NSSR 1 is detected only in the neuronal stage. Both the purified recombinant NSSR 1 and 2 proteins enhance the in vitro splicing activity of nuclear extract. Moreover, recombinant NSSR 1 protein enhances the assembly of ribonucleoprotein complexes with S100 fraction. Over-expression of NSSR 2 prevents the inclusion of either the Flip or Flop exons in the splicing of the GluR-B gene, resulting in an increase in the abnormal exon-skipping product. In contrast, transient transfection with NSSR 1 promotes the inclusion of the Flip exon so that the abnormal product is spliced to the mature spliced form. This suppression of exon skipping by NSSR 1 is observed even with co-transfection of NSSR 2.
CONCLUSIONS: NSSR 1 and 2 were cloned from mouse cDNA libraries. Results indicate that NSSR 1 may play a crucial role in the regulation of alternative splicing in neurones.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583508     DOI: 10.1046/j.1365-2443.1999.00286.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  16 in total

1.  Role of SFRS13A in low-density lipoprotein receptor splicing.

Authors:  I-Fang Ling; Steven Estus
Journal:  Hum Mutat       Date:  2010-06       Impact factor: 4.878

2.  NSSR1 is regulated by testosterone in the mouse uterus and extensively expressed in endometrial carcinoma.

Authors:  Zheng-Yu Peng; Ping-Jie Xiao; Yao Qi; Wei Zhang; Xian-Hua Chen; Ping Xu
Journal:  Tumour Biol       Date:  2010-11-12

Review 3.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

4.  Multiple properties of the splicing repressor SRp38 distinguish it from typical SR proteins.

Authors:  Chanseok Shin; Frida E Kleiman; James L Manley
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy.

Authors:  Jane Y Wu; Amar Kar; David Kuo; Bing Yu; Necat Havlioglu
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 6.  Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.

Authors:  Mo Chen; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-23       Impact factor: 94.444

7.  SRp38 regulates alternative splicing and is required for Ca(2+) handling in the embryonic heart.

Authors:  Ying Feng; Matthew T Valley; Josef Lazar; Allison L Yang; Roderick T Bronson; Stuart Firestein; William A Coetzee; James L Manley
Journal:  Dev Cell       Date:  2009-04       Impact factor: 12.270

8.  Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo.

Authors:  Eiji Sakashita; Sawako Tatsumi; Dieter Werner; Hitoshi Endo; Akila Mayeda
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5.

Authors:  Kazuo Fushimi; Payal Ray; Amar Kar; Lei Wang; Leslie C Sutherland; Jane Y Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-07       Impact factor: 11.205

10.  Identification of SRSF10 as a regulator of SMN2 ISS-N1.

Authors:  Sabrina B Frederiksen; Lise L Holm; Martin R Larsen; Thomas K Doktor; Henriette S Andersen; Michelle L Hastings; Yimin Hua; Adrian R Krainer; Brage S Andresen
Journal:  Hum Mutat       Date:  2020-12-16       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.